477 related articles for article (PubMed ID: 24238343)
1. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response.
Bailey-Bucktrout SL; Martinez-Llordella M; Zhou X; Anthony B; Rosenthal W; Luche H; Fehling HJ; Bluestone JA
Immunity; 2013 Nov; 39(5):949-62. PubMed ID: 24238343
[TBL] [Abstract][Full Text] [Related]
2. De novo-induced self-antigen-specific Foxp3+ regulatory T cells impair the accumulation of inflammatory dendritic cells in draining lymph nodes.
Alissafi T; Hatzioannou A; Ioannou M; Sparwasser T; Grün JR; Grützkau A; Verginis P
J Immunol; 2015 Jun; 194(12):5812-24. PubMed ID: 25948818
[TBL] [Abstract][Full Text] [Related]
3. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor CDR3 sequence but not recognition characteristics distinguish autoreactive effector and Foxp3(+) regulatory T cells.
Liu X; Nguyen P; Liu W; Cheng C; Steeves M; Obenauer JC; Ma J; Geiger TL
Immunity; 2009 Dec; 31(6):909-20. PubMed ID: 20005134
[TBL] [Abstract][Full Text] [Related]
5. Generation of RORγt
Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
[TBL] [Abstract][Full Text] [Related]
6. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
Sun JB; Czerkinsky C; Holmgren J
J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
[TBL] [Abstract][Full Text] [Related]
7. Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance.
Selvaraj RK; Geiger TL
J Immunol; 2008 Mar; 180(5):2830-8. PubMed ID: 18292504
[TBL] [Abstract][Full Text] [Related]
8. Thymus-Derived Regulatory T Cells Are Positively Selected on Natural Self-Antigen through Cognate Interactions of High Functional Avidity.
Kieback E; Hilgenberg E; Stervbo U; Lampropoulou V; Shen P; Bunse M; Jaimes Y; Boudinot P; Radbruch A; Klemm U; Kühl AA; Liblau R; Hoevelmeyer N; Anderton SM; Uckert W; Fillatreau S
Immunity; 2016 May; 44(5):1114-26. PubMed ID: 27192577
[TBL] [Abstract][Full Text] [Related]
9. Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity.
Gokhale AS; Gangaplara A; Lopez-Occasio M; Thornton AM; Shevach EM
J Autoimmun; 2019 Dec; 105():102300. PubMed ID: 31296356
[TBL] [Abstract][Full Text] [Related]
10. Thymic regulatory T cells arise via two distinct developmental programs.
Owen DL; Mahmud SA; Sjaastad LE; Williams JB; Spanier JA; Simeonov DR; Ruscher R; Huang W; Proekt I; Miller CN; Hekim C; Jeschke JC; Aggarwal P; Broeckel U; LaRue RS; Henzler CM; Alegre ML; Anderson MS; August A; Marson A; Zheng Y; Williams CB; Farrar MA
Nat Immunol; 2019 Feb; 20(2):195-205. PubMed ID: 30643267
[TBL] [Abstract][Full Text] [Related]
11. Blimp1 Prevents Methylation of Foxp3 and Loss of Regulatory T Cell Identity at Sites of Inflammation.
Garg G; Muschaweckh A; Moreno H; Vasanthakumar A; Floess S; Lepennetier G; Oellinger R; Zhan Y; Regen T; Hiltensperger M; Peter C; Aly L; Knier B; Palam LR; Kapur R; Kaplan MH; Waisman A; Rad R; Schotta G; Huehn J; Kallies A; Korn T
Cell Rep; 2019 Feb; 26(7):1854-1868.e5. PubMed ID: 30759395
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation controls Foxp3 gene expression.
Polansky JK; Kretschmer K; Freyer J; Floess S; Garbe A; Baron U; Olek S; Hamann A; von Boehmer H; Huehn J
Eur J Immunol; 2008 Jun; 38(6):1654-63. PubMed ID: 18493985
[TBL] [Abstract][Full Text] [Related]
13. Discrete TCR repertoires and CDR3 features distinguish effector and Foxp3+ regulatory T lymphocytes in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis.
Nguyen P; Liu W; Ma J; Manirarora JN; Liu X; Cheng C; Geiger TL
J Immunol; 2010 Oct; 185(7):3895-904. PubMed ID: 20810983
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase.
Bhowmick S; Clark RB; Brocke S; Cone RE
Int Immunol; 2011 Feb; 23(2):119-28. PubMed ID: 21273399
[TBL] [Abstract][Full Text] [Related]
15. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
[TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
17. Induction of self-antigen-specific Foxp3+ regulatory T cells in the periphery by lymphodepletion treatment with anti-mouse thymocyte globulin in mice.
Lu Y; Suzuki J; Guillioli M; Umland O; Chen Z
Immunology; 2011 Sep; 134(1):50-9. PubMed ID: 21711461
[TBL] [Abstract][Full Text] [Related]
18. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
Ghosh D; Curtis AD; Wilkinson DS; Mannie MD
J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565
[TBL] [Abstract][Full Text] [Related]
19. Low-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cells.
Chan MW; Chang CB; Tung CH; Sun J; Suen JL; Wu SF
Mol Med; 2014 Jun; 20(1):248-56. PubMed ID: 24869907
[TBL] [Abstract][Full Text] [Related]
20. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
